P1.04-47 Tumor Mutation Burden Through Hybrid Capture – Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC

Autor:	D. Mehta, N. Peled, Addie Dvir, R. Grinberg, S. Geva, L. Roisman, R. Yair, Luis E. Raez, Katie Quinn, L. Soussan Gutman, Richard B. Lanman, M. Lefterova, L. Kiedrowski
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology Circulating tumor DNA business.industry medicine.medical_treatment Mutation (genetic algorithm) Hybrid capture medicine Cancer research Immunotherapy business
Zdroj:	Journal of Thoracic Oncology. 14:S459
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2019.08.950
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7610d44971e1b8f8eb4af2e682ea2160 https://doi.org/10.1016/j.jtho.2019.08.950 Zobrazit plný text záznamu